Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy

Variable intralesional immunotherapies have recently been proposed as a means of achieving a successful eradication of recurrent and recalcitrant human papillomavirus (HPV)-induced cutaneous and anogenital warts. The bivalent HPV vaccine is one of the newly proposed immunotherapeutic agents. We inve...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Noha M. Hammad, Ayman Marei, Gamal El-Didamony, Zeinb Mortada, Mona Elradi, Amira Hamed Mohamed Afifi, Heba M. Kadry
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/985580161e3340b19bae725f2a5fa47c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!